ClinicalTrials.gg
CompletedNCT07907003Updated Oct 30, 2026

Robot-Assisted Tabletop Games for Community-Dwelling Older Adults

An interventional study of Robot-Assisted Tabletop Game Program in Healthy Aging, Cognitive Function 1, Social and Physical Function in Older Adults, sponsored by Chang Gung University of Science and Technology. Completed at 1 site in Taiwan. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Chang Gung University of Science and Technology · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Dec 2024, registered Oct 2026).
Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Study summary

This study evaluated a 12-week robot-assisted tabletop game program for community-dwelling older adults in Taiwan. Participants attended one 100-minute group session per week for 12 weeks. The program combined cognitively stimulating tabletop games with guidance from an interactive robot. The robot provided verbal instructions, task prompts, feedback, and turn-taking guidance during the activities. The tabletop games included activities related to orientation, attention, calculation, memory, language, comprehension, and visuospatial abilities.

The study used a single-group pre-post design. Participants were assessed before the program and immediately after the 12-week intervention. The study evaluated changes in physical performance, cognitive function, psychological well-being, activities of daily living, depressive symptoms, and frailty. The study was conducted at four community-based long-term care stations in New Taipei City, Taiwan.

Read the detailed description

This was a multisite, single-group pre-post quasi-experimental study conducted at four community-based Tier C long-term care stations in New Taipei City, Taiwan. The study aimed to evaluate changes in physical function, cognitive performance, psychological well-being, frailty status, and daily functioning following a 12-week robot-assisted cognitive tabletop game program among community-dwelling older adults.

Eligible participants were adults aged 65 years or older who participated in community-based health-promotion activities, were able to ambulate independently, communicate adequately, complete the study assessments, and provide written informed consent.

Participants attended one 100-minute group session per week for 12 consecutive weeks. The intervention incorporated Le-Zhi AI tabletop game materials and an interactive robot platform. The tabletop game activities were designed to stimulate multiple cognitive domains, including orientation, attention and calculation, memory, language, verbal comprehension and response, and constructional and visuospatial abilities. Reminiscence and self-efficacy components were also incorporated to encourage participation and task completion.

During each session, the interactive robot served as a structured activity facilitator by providing verbal instructions, task-related prompts, immediate feedback, and turn-taking guidance. The robot was used to support the tabletop game activities and participant engagement while maintaining face-to-face interaction among group members.

Outcome measures were administered at baseline and immediately after completion of the 12-week intervention. Assessments included the Short Physical Performance Battery (SPPB), Barthel Index for activities of daily living (ADL), instrumental activities of daily living (IADL), Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Geriatric Depression Scale-Short Form (GDS-SF), a well-being scale for older adults, and the Study of Osteoporotic Fractures (SOF) frailty index. The primary analyses examined within-participant changes from baseline to the end of the 12-week intervention.

02

Conditions studied

  • Healthy Aging
  • Cognitive Function 1, Social
  • Physical Function in Older Adults
03

In context

Lead sponsor

Chang Gung University of Science and Technology is the lead sponsor of 43 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 65 years or older.
  • Participated in community-based health-promotion activities.
  • Able to ambulate independently.
  • Able to communicate adequately and complete the study assessments.
  • Able and willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • Unable to complete the required physical-function assessments.
  • Unable to complete the required questionnaire-based assessments.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
93 participants (actual)

Study arms

  • Experimental
    Robot-Assisted Tabletop Game Program

    Participants received a 12-week robot-assisted tabletop game program consisting of one 100-minute group session per week. The program combined cognitively stimulating tabletop game activities with guidance from an interactive robot.

    Behavioral: Robot-Assisted Tabletop Game Program

Interventions

  • BehavioralRobot-Assisted Tabletop Game Program

    Participants attended one 100-minute group session per week for 12 consecutive weeks. The intervention combined cognitively stimulating tabletop game activities with an interactive robot. The tabletop games included activities targeting orientation, attention and calculation, memory, language, verbal comprehension and response, and constructional and visuospatial abilities. Reminiscence and self-efficacy components were also incorporated. During each session, the interactive robot provided verbal instructions, task-related prompts, immediate feedback, and turn-taking guidance to support participation and engagement.

06

What researchers measure

Primary outcomes

  1. Change in Physical Performance Assessed by the Short Physical Performance Battery (SPPB)

    Physical performance was assessed using the Short Physical Performance Battery (SPPB), which includes standing balance, gait speed, and repeated chair-rise tasks. Total scores range from 0 to 12, with higher scores indicating better physical performance. Change was assessed from baseline to the end of the 12-week intervention.

    Time frame: Baseline and immediately after the 12-week intervention

  2. Change in Cognitive Function Assessed by the Montreal Cognitive Assessment (MoCA)

    Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), which evaluates executive and visuospatial function, naming, attention, language, abstraction, memory, and orientation. Total scores range from 0 to 30, with higher scores indicating better cognitive performance. Change was assessed from baseline to the end of the 12-week intervention.

    Time frame: Baseline and immediately after the 12-week intervention

  3. Change in Subjective Well-Being Assessed by the Well-Being Scale

    Subjective well-being was assessed using the 14-item Well-Being Scale for older adults in Taiwan. The scale includes life-satisfaction and positive-affect dimensions and uses a four-point Likert response format. Higher total scores indicate greater subjective well-being. Change was assessed from baseline to the end of the 12-week intervention.

    Time frame: Baseline and immediately after the 12-week intervention

Secondary outcomes

  1. ADL

    Change in Activities of Daily Living Assessed by the Barthel Index

    Time frame: Baseline and immediately after the 12-week intervention

  2. IADL

    Change in Instrumental Activities of Daily Living (IADL)

    Time frame: Baseline and immediately after the 12-week intervention

  3. MMSE

    Change in Global Cognitive Function Assessed by the Mini-Mental State Examination (MMSE)

    Time frame: Baseline and immediately after the 12-week intervention

  4. GDS-SF

    Change in Depressive Symptoms Assessed by the Geriatric Depression Scale-Short Form (GDS-SF)

    Time frame: Baseline and immediately after the 12-week intervention

  5. SOF

    Change in Frailty Status Assessed by the Study of Osteoporotic Fractures (SOF) Frailty Index

    Time frame: Baseline and immediately after the 12-week intervention

07

Study locations

1 site
  • Chang Gung University of Science and Technology
    Taoyuan, Guishan District 33303, Taiwan
08

References and documents

Individual participant data

Plan to share: No — Consider briefly explaining why IPD will not or might not be shared.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2024 to primary completion in Apr 2025, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Oct 30, 2026
StartActual
Dec 17, 2024
Primary completionActual
Apr 30, 2025
CompletionActual
Apr 30, 2025
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07907003
Lead sponsor
Chang Gung University of Science and Technology
Responsible party
Sponsor
First posted
Oct 30, 2026
Start date
Dec 17, 2024
Primary completion
Apr 30, 2025
Completion
Apr 30, 2025
Last update
Oct 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion